Simplex Trading, LLC Eloxx Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$0.15 - $7.2 $60 - $2,880	400 Added 666.67%	460 $0
Q2 2022 Aug 03, 2022	SELL	$0.24 - $0.58 $168 - $408	-704 Reduced 92.15%	60 $0
Q1 2022 May 02, 2022	SELL	$0.4 - $0.72 $16,973 - $30,552	-42,434 Reduced 98.23%	764 $0
Q4 2021 Feb 23, 2022	SELL	$0.62 - $1.61 $32,552 - $84,531	-52,504 Reduced 54.86%	43,198 $30,000
Q2 2021 Aug 12, 2021	BUY	$1.35 - $3.36 $129,197 - $321,558	95,702 New	95,702 $190,000
Q1 2021 Apr 26, 2021	SELL	$3.02 - $4.54 $1,485 - $2,233	-492 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$2.42 - $4.48 $1,190 - $2,204	492 New	492 $1,000
Q2 2020 Jul 13, 2020	SELL	$1.56 - $3.65 $39 - $91	-25 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$1.96 - $7.96 $1,032 - $4,194	-527 Reduced 95.47%	25 $0
Q4 2019 Feb 05, 2020	BUY	$3.19 - $7.56 $1,760 - $4,173	552 New	552 $4,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.